Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Collecting hair for cortisol analysis is possible in low-income mother-toddler pairs.

Skin health and diseases are closely linked to metabolic processes.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Spironolactone might lower the chance of getting rosacea.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Glioblastoma cells can make androgens, which might help the tumor grow.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Certain natural compounds called terpenes may help prevent prostate cancer.

Finasteride may affect PNMT, causing side effects.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.